A new take on prions: preventing Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  TIBS -Trends in Biochemical Sciences. Regular ed

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.tibs.2008.01.004PMID 18343669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

  2007cited by this paper
• Rodent Aβ Modulates the Solubility and Distribution of Amyloid Deposits in Transgenic Mice*

  2007cited by this paper
• An estimate of the total worldwide societal costs of dementia in 2005

  2007cited by this paper
• Cellular prion protein regulates β-secretase cleavage of the Alzheimer's amyloid precursor protein

  2007cited by this paper
• Public funding for Alzheimer disease research in the United States

  2006cited by this paper
• Delineating common molecular mechanisms in Alzheimer's and prion diseases.

  2006cited by this paper
• Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

  2006cited by this paper
• The involvement of lipid rafts in Alzheimer's disease (Review)

  2006cited by this paper
• 100 Years and Counting: Prospects for Defeating Alzheimer's Disease

  2006cited by this paper
• Emerging therapeutics for Alzheimer’s disease

  2006cited by this paper
• Predicting susceptibility and incubation time of human-to-human transmission of vCJD.

  2006cited by this paper
• The prion protein and lipid rafts.

  2006cited by this paper
• The prion protein and lipid rafts (Review)

  2006cited by this paper
• Prion protein (PrP c ) promotes -amyloid plaque formation

  2005cited by this paper
• Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

  2005cited by this paper
• Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells*

  2005cited by this paper
• Expression of Cellular Prion Protein in the Frontal and Occipital Lobe in Alzheimer's Disease, Diffuse Lewy Body Disease, and in Normal Brain: An Immunohistochemical Study

  2005cited by this paper
• Prion protein (PrPc) promotes beta-amyloid plaque formation.

  2005cited by this paper
• Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis

  2005cited by this paper
• Rational targeting for prion therapeutics

  2005cited by this paper
• Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

  2004cited by this paper
• Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation

  2004cited by this paper
• Prion diseases — close to effective therapy?

  2004cited by this paper
• Coexistence of CJD and Alzheimer's disease: An autopsy case showing typical clinical features of CJD

  2004cited by this paper
• Prion protein codon 129 polymorphism and risk of Alzheimer disease

  2004cited by this paper
• Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD

  2004cited by this paper
• Pathways towards and away from Alzheimer's disease

  2004cited by this paper
• Neuronal membrane cholesterol loss enhances amyloid peptide generation

  2004cited by this paper
• Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation.

  2004cited by this paper
• Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

  2003cited by this paper
• Monoclonal antibodies inhibit prion replication and delay the development of prion disease

  2003cited by this paper
• Is loss of function of the prion protein the cause of prion disorders?

  2003cited by this paper
• ADAMs family members as amyloid precursor protein α‐secretases

  2003cited by this paper
• PRNP Val129 homozygosity increases risk for early‐onset Alzheimer's disease

  2003cited by this paper
• ADAMs family members as amyloid precursor protein alpha-secretases.

  2003cited by this paper
• Polyclonal Anti-PrP Auto-antibodies Induced with Dimeric PrP Interfere Efficiently with PrPSc Propagation in Prion-infected Cells*

  2003cited by this paper
• Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators.

  2002cited by this paper
• Identification of the Heparan Sulfate Binding Sites in the Cellular Prion Protein*

  2002cited by this paper
• Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

  2002cited by this paper
• Post‐natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration

  2002cited by this paper
• Cell-surface prion protein interacts with glycosaminoglycans.

  2002cited by this paper
• Prions: health scare and biological challenge

  2001cited by this paper
• Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies

  2001cited by this paper
• In Vivo Conversion of Cellular Prion Protein to Pathogenic Isoforms, as Monitored by Conformation-specific Antibodies*

  2001cited by this paper
• Membrane topology influences N‐glycosylation of the prion protein

  2001cited by this paper
• Early-onset familial Alzheimer disease with coexisting beta-amyloid and prion pathology.

  2000cited by this paper
• High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

  2000cited by this paper
• Nobel Lecture: Prions

  1998cited by this paper
• A transmembrane form of the prion protein in neurodegenerative disease.

  1998cited by this paper
• Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP.

  1996cited by this paper
• Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene.

  1995cited by this paper
• 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal

  1994cited by this paper
• An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques.

  1993cited by this paper
• Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

  1992cited by this paper

• Antimicrobial peptides and proteins in Alzheimer’s and Parkinson’s diseases: implications for biomarker exploration

  2025cites this paper
• The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation

  2023cites this paper
• Biomarkers associated with the pathogenesis of Alzheimer’s disease

  2023cites this paper
• β-Cleavage of the prion protein in the human eye: Implications for the spread of infectious prions and human ocular disorders.

  2021cites this paper
• Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-β or Pathologic Phenotype

  2016cites this paper
• Creutzfeldt-Jakob Disease and Alzheimer’s Disease: Does Overlap of Mechanism Mean Overlap of Treatment Methods?

  2015influential citation
• Prion Protein Is Decreased in Alzheimer's Brain and Inversely Correlates with BACE1 Activity, Amyloid-β Levels and Braak Stage

  2013cites this paper
• Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?

  2013cites this paper
• Impact of the Cellular Prion Protein on Amyloid-β and 3PO-Tau Processing

  2013cites this paper
• TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (TSES): EXPERIMENTAL APPROACHES TO PATHOGENESIS, THERAPY AND PREVENTION IN ANIMAL MODELS

  2012cites this paper
• A Common BACE1 Polymorphism Is a Risk Factor for Sporadic Creutzfeldt-Jakob Disease

  2012cites this paper
• Genetic approaches in TSE control for goats from the United Kingdom

  2012cites this paper
• A Common BACE 1 Polymorphism Is a Risk Factor for Sporadic Creutzfeldt-Jakob Disease

  2012cites this paper
• Regulation of amyloid-β production by the prion protein

  2012cites this paper
• PrP catabolites as determinants of TSE susceptibility

  2011cites this paper
• Combining in-situ proteolysis and microseed matrix screening to promote crystallization of PrPc-nanobody complexes.

  2011cites this paper
• Amyloid‐beta oligomers increase the localization of prion protein at the cell surface

  2011cites this paper
• Prion Protein Interacts with BACE1 Protein and Differentially Regulates Its Activity toward Wild Type and Swedish Mutant Amyloid Precursor Protein*

  2011cites this paper
• Immunotherapy for prion diseases: opportunities and obstacles.

  2010cites this paper
• Prion and TNFα: TAC(E)it agreement between the prion protein and cell signaling

  2010cites this paper
• Prion Protein is Reduced in Aging and in Sporadic but not in Familial Alzheimer's Disease

  2010influential citation
• Involvement of Dab1 in APP processing and beta-amyloid deposition in sporadic Creutzfeldt-Jakob patients.

  2010cites this paper
• Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)-specific antibody responses.

  2010cites this paper
• TAC(E)it agreement between the prion protein and cell signaling

  2010cites this paper
• Lipid Anchors to Proteins

  2009cites this paper
• Endogenous Viral Etiology of Prion Diseases

  2009cites this paper
• Cell biology, regulation and inhibition of β‐secretase (BACE‐1)

  2009cites this paper
• Psychotropic medications and the treatment of human prion diseases.

  2009cites this paper
• Prion protein and Alzheimer disease

  2009cites this paper
• 1 Endogenous Viral Etiology of Prion Diseases

  2009cites this paper
• Glypican-1 Mediates Both Prion Protein Lipid Raft Association and Disease Isoform Formation

  2009cites this paper
• Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration

  2009cites this paper
• Understanding BACE1: essential protease for amyloid-β production in Alzheimer’s disease

  2008cites this paper
• The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP.

  2008cites this paper